Targeted analysis of whole exome sequencing in Thai patients with neonatal diabetes

Neonatal diabetes mellitus (NDM) typically presents within the first 6 months of life and generally lacks islet autoantibodies. Genetic elucidation of NDM is a prime example of precision medicine in diabetes. However, no published genetic data exist for NDM in Thailand. We aimed to assess the genetic etiology of Thai NDM using whole exome sequencing (WES). We enrolled 14 Thai patients with NDM and measured GAD65, IA-2, and ZnT8 autoantibodies. We then performed WES and analyzed 43 NDM-related genes to identify causative variants. All subjects tested negative for the three islet autoantibodies. Eight harbored variants in well-established NDM genes (KCNJ11 [n = 5], ABCC8 [n = 1], INS [n = 2 in identical twins]). Two patients with KCNJ11 variants (rs80356616: p.Val59Met and rs8035661: p.Arg50Gln) achieved excellent glycemic control on sulfonylureas, illustrating precision therapy. The remaining six carried pathogenic variants in genes associated with monogenic diabetes, including LRBA, EIF2AK3, DOCK8, WFS1, GATA6, CISD2/SLC9B1, and COQ2. This is the first report on the genetic etiology of NDM in Thailand. WES is an effective approach to identifying variants in this rare diabetes subtype. Larger cohort studies are needed to determine the true prevalence of NDM in Thailand.

• Publication year

  2026

• Venue

  Human Genetics

• Publication date

  2026-01-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00439-025-02815-0PMID 41498801PMCID 12779698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Understanding modifiable caregiver factors contributing to child development among young children in rural Malawi

  2024cited by this paper
• Investigation of Monogenic Diabetes Genes in Thai Children with Autoantibody Negative Diabetes Requiring Insulin

  2024cited by this paper
• Neonatal diabetes mellitus around the world: Update 2024

  2024cited by this paper
• VarCards2: an integrated genetic and clinical database for ACMG-AMP variant-interpretation guidelines in the human whole genome

  2023cited by this paper
• ATP-Sensitive Potassium Channels in Hyperinsulinism and Type 2 Diabetes: Inconvenient Paradox or New Paradigm?

  2022cited by this paper
• ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents

  2022influential reference
• Young‐onset diabetes patients in Thailand: Data from Thai Type 1 Diabetes and Diabetes diagnosed Age before 30 years Registry, Care and Network (T1DDAR CN)

  2021influential reference
• Neonatal Diabetes Mellitus

  2020cited by this paper
• Update of variants identified in the pancreatic β‐cell KATP channel genes KCNJ11 and ABCC8 in individuals with congenital hyperinsulinism and diabetes

  2020cited by this paper
• Influences of early child nutritional status and home learning environment on child development in Vietnam

  2018cited by this paper
• ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents

  2018cited by this paper
• Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.

  2017cited by this paper
• The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study

  2017cited by this paper
• A novel CISD2 mutation associated with a classical Wolfram syndrome phenotype alters Ca2+ homeostasis and ER-mitochondria interactions

  2017cited by this paper
• KBG Syndrome: A Case Report and Longitudinal Assessment of Long‐Acting Recombinant Human Growth Hormone Therapy

  2015cited by this paper
• Patient With iDEND Syndrome–Related Mutation

  2014cited by this paper
• Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births

  2011cited by this paper
• Transition from insulin to glyburide in a 4‐month‐old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11

  2007cited by this paper
• The Walter B. Cannon Physiology in Perspective Lecture, 2007. ATP-sensitive K+ channels and disease: from molecule to malady.

  2007cited by this paper
• Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.

  2006cited by this paper
• Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype

  2006cited by this paper
• Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.

  2005cited by this paper
• Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.

  2004cited by this paper

• No citing papers are available for this paper.